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Nicotinamide	adenine	dinucleotide	 (NAD)	exists	 in	an	oxidized	form	(NAD+) and a re-
duced	form	(NADH).	NAD+ plays crucial roles in cancer metabolism, including in cellular 
signaling,	energy	production	and	redox	regulation.	However,	it	remains	unclear	whether	
NAD(H)	pool	size	(NAD+	and	NADH)	could	be	used	as	biomarker	for	colon	cancer	pro-
gression.	Here,	we	showed	that	the	NAD(H)	pool	size	and	NAD+/NADH	ratio	both	in-
creased	during	colorectal	cancer	(CRC)	progression	due	to	activation	of	the	NAD+ salvage 
pathway	mediated	by	nicotinamide	phosphoribosyltransferase	(NAMPT).	The	NAMPT	
expression	was	upregulated	in	adenoma	and	adenocarcinoma	tissues	from	CRC	patients.	
The	 NADH	 fluorescence	 intensity	 measured	 by	 two-	photon	 excitation	 fluorescence	
(TPEF)	microscopy	was	consistently	increased	in	CRC	cell	lines,	azoxymethane/dextran	
sodium	sulfate	(AOM/DSS)-	induced	CRC	tissues	and	tumor	tissues	from	CRC	patients.	
The	increases	in	the	NAD(H)	pool	inhibited	the	accumulation	of	excessive	reactive	oxy-
gen	species	(ROS)	levels	and	FK866,	a	specific	inhibitor	of	NAMPT,	treatment	decreased	
the	CRC	nodule	size	by	increasing	ROS	levels	in	AOM/DSS	mice.	Collectively,	our	results	
suggest	that	NAMPT-	mediated	upregulation	of	the	NAD(H)	pool	protects	cancer	cells	
against	detrimental	oxidative	stress	and	that	detecting	NADH	fluorescence	by	TPEF	mi-
croscopy	could	be	a	potential	method	for	monitoring	CRC	progression.
K E Y W O R D S
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1  | INTRODUC TION
Worldwide,	colorectal	cancer	(CRC)	is	the	third	most	common	cancer	
diagnosed in men and the second most common in women. It also has 
the fourth highest cancer mortality rate in men and the third highest 
in women.1	The	vast	majority	of	CRC	cases	are	 linked	 to	environ-
mental	causes,	such	as	diet,	exercise,	weight,	food-	borne	mutagens,	
specific intestinal commensals and chronic intestinal inflammation.2 
For	example,	patients	with	inflammatory	bowel	disease,	such	as	ul-
cerative	 colitis	 or	Crohn’s	 disease,	 are	 5	 to	7	 times	more	 likely	 to	
develop	CRC.3-6 In addition to cancer cells, tumors are composed 
of various immune and inflammatory cells, including macrophages, 
neutrophils	 and	 T	 lymphocytes.	 These	 cells	 can	 influence	 cancer	
cells via the production of cytokines, chemokines, growth factors 
and	 reactive	 oxygen	 species	 (ROS).7	 ROS	 cause	DNA	damage,	 re-
sulting in an accumulation of gene mutations, and activate specific 
signaling pathways that promote tumor development.8	However,	 if	
ROS levels increase over a certain threshold that is unfavorable for 
cellular	survival,	they	may	induce	cytotoxicity	and	limit	cancer	pro-
gression.9	Cancer	cells	should	survive	under	metabolic	stress	condi-
tions,	such	as	nutrient	deprivation,	hypoxia	and	inflammation,	which	
lead	to	the	accumulation	of	excessive	ROS	levels	during	cancer	pro-
gression.10 For cancer to progress under such circumstances, cancer 
cells	must	acquire	adaptive	mechanisms	for	protection	against	 the	
potential	toxic	effects	induced	by	elevated	ROS	levels.
Nicotinamide	adenine	dinucleotide	(NAD)	is	a	critical	coenzyme	
that	exists	 in	both	oxidized	 (NAD+)	and	reduced	 (NADH)	forms.	 In	
mammals,	 NAD+	 is	 biosynthesized	 via	 2	 major	 pathways:	 the	 de	
novo and salvage pathways.11	 The	 salvage	 pathway	 is	 important	
for	the	maintenance	of	NAD+ levels in cancer cells and works via 2 
major pathways, one using nicotinamide phosphoribosyltransferase 
(NAMPT)	and	the	other	using	nicotinate	phosphoribosyltransferase	
(NAPRT).	NAMPT	acts	as	a	rate-	limiting	enzyme	in	the	salvage	path-
way and works by transferring a phosphoribosyl group to nicotin-
amide	(NAM)	to	form	nicotinamide	mononucleotide	(NMN).	NMN	is	
then	converted	into	NAD+ by nicotinamide mononucleotide adenyl-
yltransferase	(NMNAT).	NAPRT	is	involved	in	the	synthesis	of	NAD+ 
from nicotinic acid.12	NAMPT	is	upregulated	in	various	cancer	types,	
including prostate, breast, colorectal, gastric and liver cancers,13 and 
could	be	induced	in	response	to	stressors	such	as	genotoxic	stress	
and nutrient deprivation.14	 FK866,	 a	 specific	 inhibitor	 of	NAMPT,	
has	been	reported	to	inhibit	breast	cancer	progression	in	a	xenograft	
model,15	and	colon	cancer	progression	 in	an	 inflammation-	induced	
model.16	Cancer	cells	are	reported	to	have	a	high	rate	of	NAD+ turn-
over	and	a	low	ratio	of	cytosolic	NAD+/NADH	due	to	their	elevated	
metabolic needs.12	Therefore,	it	remains	to	be	resolved	whether	the	
NAD+/NADH	 ratio	 and	 the	NAD(H)	 pool	 size	 can	 regulate	 cancer	
progression and the underlying mechanism.
Because	 NADH	 is	 autofluorescent,	 it	 can	 be	 utilized	 in	 non-	
destructive	optical	imaging	techniques	without	the	use	of	exogenous	
labeling	agents.	 Indeed,	 the	 redox	 ratio,	which	 is	 the	 fluorescence	
intensity	ratio	of	NADH	and	FAD	(NADH/FAD),	 is	commonly	used	
in optical metabolic imaging methods. Previous studies demon-
strated	that	the	redox	ratio	was	increased	in	human	papillomavirus-	
transformed	cells	and	estrogen	receptor-	positive	breast	cancer	cell	
lines.17,18	Two-	photon	excitation	fluorescence	(TPEF)	microscopy	is	
well	 suited	 for	 high-	resolution,	 3-	dimensional,	 non-	invasive	 mea-
surements of deep regions within living tissue.19,20	 The	 detection	
of	 NADH	 by	 TPEF	microscopy	 during	 CRC	 progression	 in	 a	 non-	
invasive manner would be important for developing not only a diag-
nostic	biomarker	but	also	therapeutics	targets	associated	with	NAD+ 
pathways.
In the present study, we investigated the correlation between 
the	NAD(H)	pool	size	and	CRC	progression	and	evaluated	NADH	as	
a	potential	prognostic	marker.	The	NAD(H)	pool	size	was	increased	
during colon cancer progression by activating the salvage pathway 
of	NAD+	synthesis	and	could	protect	tumor	cells	from	excessive	ox-
idative	stress	 induced	by	 inflammation.	NADH	fluorescence	 inten-
sity,	as	measured	by	TPEF	microscopy,	was	consistently	elevated	in	
tumor	 tissues	 from	 CRC	 patients,	 suggesting	 that	 NADH	 fluores-
cence	intensity	could	be	a	biomarker	for	CRC	progression.
2  | MATERIAL S AND METHODS
More	 detailed	 descriptions	 of	 cell	 culture,	 drug	 treatments,	west-
ern blot analysis, immunohistochemistry, immunofluorescence, sta-
ble	gene	knockdown,	gene	silencing	with	siRNA,	NAD+/NADH	and	
NADP+/NADPH	assay,	two-	photon	excitation	fluorescence	imaging,	
redox	analysis	and	RT-	PCR	are	provided	in	the	supporting	informa-
tion	(Appendix	S1).
2.1 | Azoxymethane/dextran sodium sulfate 
tumor model
C57BL/6J	mice	(6	weeks	old)	were	i.p.	injected	with	10	mg/kg	azox-
ymethane	(AOM)	(A5486,	Sigma	Aldrich,	St	Louis,	MO,	USA).	After	
7 days, the mice were administered 2 cycles of 2% DSS (160110, 
MP	Biomedical,	Solon,	OH,	Canada)	for	7	days.	The	mice	were	killed	
60	days	after	the	cessation	of	DSS	treatment.	The	colons	of	those	
mice were dissected longitudinally and washed with PBS immedi-
ately	after	sacrifice.	The	colonic	tissues	were	laid	down	with	the	mu-
cosa	layer	facing	up	on	microscope	slides	for	TPEF	imaging.
2.2 | Reactive oxygen species assay
After	 24	h	 of	 H2O2	 treatment,	 carboxy-	H2DCFDA	 (Invitrogen,	
Carlsbad,	CA,	USA)	was	 added	 to	 each	dish	 at	 a	 concentration	of	
20 μmol/L	for	30	minutes.	The	cells	were	incubated	for	45	minutes	
with medium, and the fluorescence levels were determined using a 
microplate	reader	 (Tecan,	Grödig,	Austria).	To	detect	ROS	levels	 in	
mouse	tissues,	carboxy-	H2DCFDA	(Invitrogen)	was	added	to	colon	
tissues at a concentration of 20 μmol/L	and	 incubated	 for	15	min-
utes.	 The	 tissues	 were	 washed	 with	 PBS.	 The	 fluorescence	 was	
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detected	at	950	nm	excitation	by	two-	photon	microscopy	(TCS	SP5	
II,	Leica,	Wetzlar,	Germany).
2.3 | Statistical analysis
Statistical	analyses	were	performed	using	a	2-	tailed	Student’s	t test. 
P < .05	was	 considered	 statistically	 significant.	 All	 samples	 except	
for	animal	samples	were	prepared	in	triplicate	for	every	experiment.	
The	data	represent	at	least	3	independent	experiments	and	are	pre-
sented as the mean ± SD.
2.4 | Study approval
Human	 colon	 cancer	 specimens	 and	 their	 paired	 normal	 speci-
mens	were	obtained	from	Asan	Bio-	Resource	Center.	All	processes	
were	 performed	 under	 the	 approval	 of	 the	 Asan	Medical	 Center	
Institutional	Review	Board.	All	animal	experiments	were	performed	
in accordance with the guidelines and regulations and with the ap-
proval	 of	 The	 Institutional	 Animal	 Care	 and	 Use	 Committees	 at	
POSTECH.
3  | RESULTS
3.1 | The NAD(H) pool size could increase in 
malignant colorectal cancer cell lines resulting from 
activation of the salvage pathway of NAD+ synthesis
As	 cancer	 cells	 require	 the	 rapid	 turnover	 of	NAD+,12 we investi-
gated	 the	 correlation	of	NAD(H)	pool	 size	 and	NAD+/NADH	 ratio	
with	 colon	 cancer	 progression.	We	measured	 each	 level	 of	NAD+	
and	NADH	in	normal	gut	epithelial	CCD-	18Co	cells	and	in	CRC	cell	
lines,	including	the	SW480,	RKO	and	HCT116	cell	lines	by	enzymatic	
method.	We	obtained	NAD(H)	pool	 size	by	adding	 levels	of	NAD+ 
and	NADH	 and	 the	 ratio	 of	 NAD+/NADH.	 The	NAD(H)	 pool	was	
F IGURE  1 The	NAD+	salvage	pathway	was	activated,	and	the	NAD(H)	pool	size	was	increased	in	malignant	colorectal	cancer	(CRC)	
cell	lines.	A,	B,	Levels	of	NAD+	and	NADH	were	quantified	in	normal	gut	epithelial	cells	(CCD-	18Co)	and	CRC	cell	lines	(SW480,	RKO	
and	HCT116).	C,	NAD+/NADH	ratios	were	measured	in	the	indicated	cells.	D,	The	NAD(H)	pool	represented	the	sum	of	the	NAD+ and 
NADH	levels.	E,	NADH	fluorescence	was	detected	in	gut	epithelial	cells	and	CRC	cell	lines	by	two-	photon	excitation	fluorescence	(TPEF)	
microscopy	(scale	bar,	50	μm).	F,	mRNA	levels	of	nicotinamide	phosphoribosyltransferase	(NAMPT),	nicotinate	phosphoribosyltransferase	
(NAPRT),	NMNAT1,	CD38	and	PARP	were	assessed	by	quantitative	RT-	PCR	analysis.	G,	Protein	levels	were	measured	by	western	blotting	
using	whole-	cell	lysates.	H,	I,	Protein	levels	were	analyzed	by	densitometry	using	the	ImageJ	software.	The	bars	represent	the	mean	±	SD	
(n = 9). *P	<	.05	by	Student’s	t test
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larger	in	the	CRC	cell	lines	than	in	normal	gut	epithelial	cells	due	to	
the	increase	in	both	the	NAD+	and	NADH	levels	(Figure	1A-	C).	The	
NAD+/NADH	ratio	was	also	higher	in	the	CRC	cell	lines	(Figure	1D).	
In	 addition,	 NADH	 fluorescence	 detected	 using	 TPEF	microscope	
at	a	740-	nm	wavelength	was	consistently	stronger	 in	the	CRC	cell	
lines	 than	 in	 the	normal	 gut	 epithelial	 cells,	 InEpC	and	CCD-	18Co	
cells	(Figure	1E).	Therefore,	CRC	cells	were	found	to	maintain	a	large	
NAD(H)	pool	size	and	a	high	NAD+/NADH	ratio.
To	 identify	 which	 factors	 could	 increase	 the	 NAD(H)	 pool	
and	NAD+/NADH	 ratio	 in	 CRC	 cells,	 we	 examined	 the	 levels	 of	
enzymes	that	produced	or	consumed	NAD+.	The	mRNA	and	pro-
tein	levels	of	enzymes	in	the	salvage	pathway	of	NAD+ synthesis, 
such	as	NAMPT,	NAPRT	and	NMNAT1,	were	upregulated	in	CRC	
cell	lines	relative	to	normal	gut	epithelial	cells.	However,	those	of	
enzymes	consuming	NAD+,	 such	as	CD38	and	PARP-	1,	were	not	
correlated	with	the	sizes	of	 the	NAD(H)	pool	or	 ratios	of	NAD+/
NADH	 (Figure	1F-	I),	 suggesting	 that	 activation	 of	 the	 salvage	
pathway	could	increase	both	the	NAD(H)	pool	size	and	the	NAD+/
NADH	ratio	in	CRC	cells.
3.2 | NADH fluorescence reflects the NAD(H) 
pool size
We	 next	 examined	 whether	 inhibition	 of	 the	 enzymes	 NAMPT,	
NAPRT	 and	 NMNAT1	 could	 decrease	 NAD+	 and	 NADH	 levels.	
Knockdown	 of	 NAPRT	 or	 NMNAT1	 barely	 reduced	 the	 NAD+ 
and	 NADH	 levels,	 whereas	 knockdown	 of	 NAMPT	 significantly	
decreased	both	the	NAD+	(Figure	2A)	and	NADH	(Figure	2B)	lev-
els,	 leading	 to	 a	 reduced	 NAD(H)	 pool	 (Figure	2C).	 The	 NAD+/
NADH	ratio	was	also	reduced	by	NAMPT	knockdown	(Figure	2D).	
F IGURE  2 Nicotinamide	phosphoribosyltransferase	(NAMPT)	inhibition	reduced	the	NAD(H)	pool	size.	A-	D,	Scrambled	siRNA	and	
siRNA	targeting	NAMPT,	nicotinate	phosphoribosyltransferase	(NAPRT)	or	NMNAT1	were	transfected	into	RKO	cells	for	60	h,	followed	by	
NAD+	treatment	for	12	h.	Levels	of	NAD+	and	NADH	were	assessed,	in	addition	to	the	NAD+/NADH	ratio.	E-H,	Scrambled	siRNA	or	siRNA	
targeting	NAMPT	was	transfected	into	RKO	cells	for	60	h,	followed	by	NMN	treatment	for	12	h.	Levels	of	NAD+	and	NADH	as	well	as	the	
NAD+/NADH	ratio	were	assessed.	I-	L,	NAD+	and	NADH	levels	were	measured	following	FK866	treatment	for	24	h	in	colorectal	cancer	
(CRC)	cell	lines.	M,	NADH	fluorescence	was	detected	by	two-	photon	excitation	fluorescence	(TPEF)	microscopy	following	FK866	treatment	
for	4	h	in	CRC	cell	lines	(scale	bar,	50	μm).	N,	NADH	fluorescence	intensity	in	individual	cells	was	quantified	using	the	MATLAB	program.	The	
bars represent the mean ± SD (n = 9). *P	<	.05	by	Student’s	t test
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Moreover,	 NMN	 treatment	 restored	 the	 levels	 of	 NAD+, and 
NADH	and	increased	the	NAD(H)	pool	and	NAD+/NADH	ratio	in	
NAMPT-	knockdown	 cells	 (Figure	2E-	H),	 indicating	 that	 NAMPT	
could	not	only	 critically	 determine	 the	NAD+ levels but also the 
NAD(H)	pool	size.
Nicotinamide	 phosphoribosyltransferase	 inhibition	 through	
treatment	with	 FK866	 for	 12	hours	 slightly	 decreased	 the	NAD+/
NADH	 ratio	 (Figure	2L)	 but	 dramatically	 reduced	 the	 NAD+ and 
NADH	levels	(Figure	2I,J),	resulting	in	the	depletion	of	the	NAD(H)	
pool	(Figure	2K).	Consistently,	the	NADH	fluorescence	intensity	was	
dramatically	decreased	in	CRC	cells	following	treatment	with	FK866	
for	4	hours	(Figure	2M,N),	suggesting	that	the	NADH	fluorescence	
intensity	using	TPEF	microscopy	could	be	positively	correlated	with	
the	NADH	pool	size.
Both	 NADH	 and	 NADPH	 can	 be	 excited	 at	 the	 same	wave-
length;	therefore,	we	further	investigated	the	influence	of	NADPH	
on	the	fluorescence	intensity	determined	by	TPEF	microscopy	at	a	
740-	nm	wavelength.	For	this	purpose,	we	transfected	siRNA	spe-
cific	 to	 glucose-	6-	phosphate	 dehydrogenase	 (G6PD),	 an	 enzyme	
that	 is	critical	 for	NADPH	production	 (Figure	S1E).	G6PD	knock-
down	 specifically	 downregulated	 NADPH	 levels	 (Figure	 S1A-	D)	 
and	 did	 not	 reduce	 the	 fluorescence	 intensity	 (Figure	 S1E,F).	
F IGURE  3 The	NAD(H)	pool	size	was	increased	in	azoxymethane/dextran	sodium	sulfate	(AOM/DSS)-	induced	colorectal	cancer.	A,	
Experimental	scheme	used	to	induce	colorectal	cancer	(CRC)	formation	in	C57BL/6	mice:	after	an	initial	injection	of	10	mg/kg	AOM,	2%	
DSS	was	administered	via	the	drinking	water,	followed	by	normal	drinking	water.	B,	Representative	images	of	excised	mouse	colon	tissues.	
Mice	were	killed	2	mo	after	DSS	treatment	(n	=	5	per	time	point).	C,	Tumor	tissues	were	embedded	in	paraffin	and	sectioned	(5	μm thick). 
The	sections	were	stained	with	H&E	(scale	bar,	200	μm).	D,	Protein	levels	of	nicotinamide	phosphoribosyltransferase	(NAMPT),	nicotinate	
phosphoribosyltransferase	(NAPRT)	and	NMNAT1	were	assessed	by	western	blotting	of	tissue	lysates.	E-	H,	Levels	of	NAD+	and	NADH	were	
quantified	in	normal	colon	tissue	and	AOM/DSS-	induced	CRC	tissue.	The	bars	represent	the	mean	±	SD	(n	=	5).	*P	<	.05	by	Student’s	t test. I, 
NADH	and	FAD	fluorescence	levels	were	detected	in	normal	colon	tissue	and	AOM/DSS-	induced	CRC	tissue	at	the	indicated	depths	of	20,	
40 and 60 μm (scale bar, 100 μm).	J,	NADH	fluorescence	intensity	at	the	indicated	depth	was	quantified.	*P	<	.05	by	Student’s	t	test.	K,	The	
NADH/FAD	ratios	in	normal	tissue	and	AOM/DSS-	induced	CRC	tissue	were	quantified	at	the	indicated	depths	using	the	MATLAB	program
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NAMPT	 knockdown	 led	 to	 a	 decrease	 in	 fluorescence	 intensity	
(Figure	S1F,G).	This	 result	was	 likely	because	2-	fold	more	NADH	
was	present	than	NADPH	(Figure	S1B,D).	Our	observations	 indi-
cated	 that	NAMPT	 could	 regulate	 the	NAD(H)	 pool	 size	 by	me-
diating	NAD+	 influx	and	that	the	fluorescence	intensity	detected	
by	 TPEF	 microscopy	 at	 a	 740-	nm	 wavelength	 could	 reflect	 the	
NAMPT-	mediated	regulation	of	the	NAD(H)	pool	size.
3.3 | The NAD(H) pool increases in azoxymethane/
dextran sodium sulfate- induced colon cancer
The	increased	NAD(H)	pools	found	in	CRC	cell	lines	prompted	us	to	
investigate	whether	the	NAD(H)	pool	was	also	augmented	in	AOM/
DSS	mice,	a	model	created	by	 injecting	C57BL/6J	mice	with	a	sin-
gle	dose	of	 the	carcinogen	AOM,	 followed	by	2	cycles	of	DSS	ad-
ministration	(Figure	3A).	Mice	exposed	to	the	AOM/DSS	treatment	
regimen	developed	CRC	(Figure	3B,C).	The	NAD+ salvage pathway 
was	 consistently	 activated	 in	 the	AOM/DSS	mice,	 as	 indicated	by	
the	 overexpression	 of	NAMPT,	NAPRT	 and	NMNAT1	 (Figure	3D).	
As	NAMPT	was	critical	for	the	increased	NAD(H)	pool	size	(Figure	2),	
we	further	examined	the	types	of	cells	that	upregulated	NAMPT	in	
tumor	tissues.	NAMPT	was	entirely	upregulated	in	colon	cancer	tis-
sues, including colon cancer cells and immune cells. F4/80, a mac-
rophage	marker,	 and	CD3,	 a	 T	 cell	marker,	were	 also	 increased	 in	
AOM/DSS-	induced	 CRC	 tissues	 and	 co-	localized	 with	 NAMPT	
(Figure	S2).	Next,	we	compared	the	NAD(H)	pool	size	between	the	
normal	 gut	 epithelium	 and	 AOM/DSS-	induced	 tumor	 tissue.	 Both	
NAD+	 and	 NADH	 levels	 were	 markedly	 increased	 in	 AOM/DSS-	
induced	tumor	tissue	(Figure	3E,F),	leading	to	a	1.6-	fold	increase	in	
the	NAD(H)	pool	size	(Figure	3G).	The	NAD+/NADH	ratio	was	also	
increased	by	1.2-	fold	(Figure	3H).	Consistent	with	the	above	results,	
the	NADH	fluorescence	intensity	and	the	redox	ratio	(NADH/FAD	
fluorescence)	were	also	elevated	in	AOM/DSS-	induced	tumor	tissue	
(Figure	3I-	K).	Our	data	indicated	that	the	NAD(H)	pool	size	increases	
F IGURE  4 Nicotinamide	phosphoribosyltransferase	(NAMPT)	expression	was	induced	by	inflammation-	induced	reactive	oxygen	species	
(ROS)	production	and	protected	colorectal	cancer	(CRC)	cells	from	oxidative	stress	by	increasing	the	NAD(H)	pool	size.	A,	In	normal	tissue	
and	azoxymethane/dextran	sodium	sulfate	(AOM/DSS)-	induced	colorectal	cancer	(CRC)	tissue,	NADH	fluorescence	was	measured	by	two-	
photon	excitation	fluorescence	(TPEF)	microscopy.	ROS	levels	were	also	determined	by	TPEF	microscopy	following	incubation	with	carboxy-	
H2DCFDA	dye	(scale	bar,	100	μm).	B,	Tumor	tissues	were	embedded	in	paraffin	and	sectioned	(5-	μm	thick).	The	sections	were	stained	
with	anti-	F4/80	and	anti-	IFN-	γ	antibodies	and	counterstained	with	hematoxylin	(scale	bar,	200	μm).	C,	NAMPT	expression	was	induced	by	
exogenous	treatment	with	500	μmol/L	H2O2	in	CRC	cell	lines.	D,	Protein	levels	were	analyzed	by	densitometry	using	the	ImageJ	software.	E,	
HCT116	cells	were	treated	with	800	μmol/L	H2O2	or	1	mmol/L	NAD
+	for	24	h.	Cell	death	was	assessed	by	trypan	blue	staining.	F,	RKO	cells	
were treated with 800 μmol/L	H2O2	or	1	mmol/L	NAC	for	24	h.	Cell	death	was	assessed	by	trypan	blue	staining.	G,	RKO	cells	were	treated	
with 800 μmol/L	H2O2	for	12	h.	ROS	measurements	were	performed	using	carboxy-	H2DCFDA.	The	bars	represent	the	mean	±	SD	(n	=	9).	
*P	<	0.05	by	Student’s	t test. a.u., arbitrary unit
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during	CRC	progression	and	that	imaging	NADH	fluorescence	using	
TPEF	microscopy	could	be	a	robust	method	for	detecting	tumor	tis-
sue	in	AOM/DSS	mice.
3.4 | Increases in the NAS(H) pool by nicotinamide 
phosphoribosyltransferase protect cancer cells 
against detrimental oxidative stress
Azoxymethane/dextran	sodium	sulfate	mice	have	been	widely	uti-
lized	to	examine	the	role	of	inflammation	in	colon	carcinogenesis	
and	 the	 contribution	 of	 inflammation-	induced	 ROS	 production	
to	CRC	progression.21	Because	NAMPT	has	been	reported	to	 in-
crease	 the	antioxidant	capacity	of	 tumor	cells,15 we investigated 
whether	 the	 NAD(H)	 pool	 increased	 by	 NAMPT	would	 regulate	
the	inflammation-	induced	ROS	levels	in	AOM/DSS	mice.	The	ROS	
levels	were	significantly	increased	in	AOM/DSS	mice	(Figure	4A).	
Interestingly,	the	regions	of	tumor	tissues	with	high	levels	of	NADH	
exhibited	 low	 levels	 of	 ROS	 relative	 to	 the	 surrounding	 regions	
with	low	levels	of	NADH	(Figure	4A).	To	confirm	that	ROS	produc-
tion was increased by inflammatory cytokines and immune cells in 
AOM/DSS	mice,	we	detected	 IFN-	γ and the macrophage marker 
F4/80	 by	 IHC	 experiments.	 Both	 proteins	 were	 expressed	 at	
higher	levels	in	CRC	tissues	than	in	normal	gut	tissues	(Figure	4B).	
These	 results	 indicate	 that	 the	 ROS	 level	 was	 increased	 by	 in-
flammation	 in	AOM/DSS	mice	 and	was	 downregulated	 in	 tumor	
regions	with	 large	NAD(H)	 pools.	 Our	 findings	 suggest	 that	 the	
increase	in	NAD(H)	pools	in	tumor	tissues	could	reduce	the	detri-
mental	oxidative	stress	induced	by	inflammation.
Next,	 we	 investigated	 whether	 decreasing	 the	 excessive	 ROS	
levels	 by	 increasing	 the	NADH	pool	 size	would	 promote	CRC	 cell	
survival.	 We	 found	 that	 exogenous	 H2O2 treatment increased 
NAMPT	 expression	 by	 approximately	 3-	fold	 in	 CRC	 cell	 lines	 and	
produced	only	marginal	changes	in	normal	gut	epithelial	CCD-	18Co	
cells	(Figure	4C,D).	Moreover,	NAMPT	knockdown	and	FK866	treat-
ment	 dramatically	 increased	 CRC	 cell	 death	 and	 ROS	 levels	 upon	
H2O2 treatment, and this effect was rescued by treatment with 
F IGURE  5 FK866	inhibited	colorectal	cancer	(CRC)	progression	in	azoxymethane/dextran	sodium	sulfate	(AOM/DSS)	mice.	A,	
Experimental	scheme	used	to	administer	FK866	to	AOM/DSS	mice.	FK866	(10	mg/kg)	was	injected	i.p.	21	d	after	the	final	DSS	cycle.	B,	
Representative	images	of	excised	mouse	colon	tissue.	Mice	were	killed	21	d	after	the	initial	FK866	injection	(n	=	5	per	time	point).	C,	Tumor	
tissues	were	embedded	in	paraffin	and	sectioned	(5	μm	thick).	The	sections	were	stained	with	H&E	(scale	bar,	200	μm).	D,	The	tumor	surface	
size	was	measured.	*P	<	.05	by	Student’s	t	test.	E,	The	NADH	fluorescence	and	reactive	oxygen	species	(ROS)	levels	were	determined	by	
two-	photon	excitation	fluorescence	(TPEF)	microscopy	after	incubation	with	carboxy-	H2DCFDA	dye	(scale	bar,	100	μm)
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NAD+	 or	NAC	 (Figure	4E-	G).	 Collectively,	 these	 findings	 indicated	
that	upregulation	of	NAMPT	by	inflammation-	induced	ROS	produc-
tion	 protected	 tumor	 cells	 against	 excessive	 oxidative	 stress	 and	
promoted	CRC	progression.
3.5 | FK866 inhibits colorectal cancer progression in 
azoxymethane/dextran sodium sulfate mice
To	 investigate	 whether	 NAMPT	 inhibition	 could	 suppress	 CRC	
progression	 in	 AOM/DSS	mice,	 FK866	was	 i.p.	 injected	 into	mice	
21	days	after	DSS	treatment	(Figure	5A).	We	confirmed	that	FK866	
treatment	suppressed	AOM/DSS-	induced	progression	of	CRC	by	im-
aging	the	large	intestine	(Figure	5B).	FK866	treatment	did	not	induce	
morphological	changes	in	the	gut	crypt	organization	(Figure	5C),	al-
though	the	tumor	surface	area	was	reduced	by	FK866	(Figure	5D).	
FK866	treatment	decreased	NADH	fluorescence	intensity	and	sig-
nificantly	increased	ROS	levels	in	AOM/DSS	mice	(Figure	5E).	These	
data	 indicated	that	FK866	could	 inhibit	CRC	progression	 in	AOM/
DSS	mice	by	causing	excessive	accumulation	of	ROS.
3.6 | The NAD(H) pool increases in human 
colorectal tumor tissue
As	noted	above,	larger	NAD(H)	pools	were	observed	in	CRC	cell	lines	
and	AOM/DSS	mouse	tissues	than	in	normal	cell	lines	and	normal	gut	
tissue.	Therefore,	we	examined	whether	the	NAD(H)	pool	size	was	
also	increased	in	tumor	tissues	from	adenocarcinoma	patients	(Table	
S1).	 Similar	 to	 AOM/DSS	 mice,	 the	 NADH	 fluorescence	 intensity	
was	significantly	stronger	in	tumor	tissue	than	in	non-	tumor	tissue	
(Figures	6A,C	 and	S3A-	G).	 In	 contrast,	 FAD	 fluorescence	 intensity	
was	reduced	in	CRC	tissue	compared	with	non-	tumor	tissue,	leading	
to	an	increased	redox	ratio	in	CRC	tissue	(Figure	6B).	Consistent	with	
the	NADH	fluorescence	intensity,	NAMPT	protein	levels	were	also	
upregulated	in	tumor	tissues	(Figures	6D	and	S3A-	G).	Next,	we	con-
firmed	that	the	NAMPT	mRNA	levels	were	upregulated	in	adenoma	
and	adenocarcinoma	tissues	relative	to	non-	tumor	tissues	collected	
from	patients	 (Figure	6E-	G	 and	Table	 S2).	Our	 data	 indicated	 that	
upregulated	NAMPT	expression	could	increase	the	NAD(H)	pool	size	
in	the	tumor	tissues	of	CRC	patients.
F IGURE  6 The	NAD(H)	pool	size	was	increased	in	human	colorectal	tumor	tissue.	A,	Representative	images	of	tissues	from	colorectal	
cancer	(CRC)	patients.	NADH	and	FAD	fluorescence	levels	were	detected	in	non-	tumor	and	tumor	tissues	from	CRC	patients	by	two-	photon	
excitation	fluorescence	(TPEF)	microscopy	(scale	bar,	50	μm).	B,	NADH/FAD	ratios	were	quantified	using	the	MATLAB	program.	C,	NADH	
fluorescence intensities of patient tissues at 40 μm	were	quantified.	***P	<	.0001	by	Student’s	t test. D, Patient tissues were embedded 
in	paraffin	and	sectioned	(5	mm	thick).	The	sections	were	stained	with	anti-	nicotinamide	phosphoribosyltransferase	(NAMPT)	antibody	
(upper)	and	H&E	(down)	(scale	bar,	200	μm).	E-	G,	Nicotinamide	phosphoribosyltransferase	(NAMPT)	mRNA	levels	were	quantified	in	
adenocarcinoma	and	adenoma	tissues	from	CRC	patients	by	quantitative	PCR
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4  | DISCUSSION
Cancer	cells	require	significantly	more	NAD+ than normal cells due 
to	their	elevated	metabolic	needs.	The	cytosolic	NAD+/NADH	ratio	
was	 reported	 to	 downregulate	 in	 cancer	 cell	 lines	 such	 as	H1299,	
U87	and	MDA-	MB468,	as	observed	by	genetically	engineered	fluo-
rescent	 biosensors	 that	 can	 measure	 protein-	unbound	 species	 of	
NAD(H).22,23	In	this	study,	we	quantified	the	total	NAD(H)	levels	in	
whole	cell	lysates	by	enzymatic	assays.	Both	the	NAD+/NADH	ratio	
and	 NAD(H)	 pool	 size	 were	 increased	 according	 to	 colon	 cancer	
progression	in	response	to	enhanced	NAD+	influx	due	to	upregula-
tion	of	 enzymes	 in	NAD+	 salvage	 synthesis.	 In	 particular,	NAMPT	
was	 critical	 to	 maintain	 the	 NAD(H)	 pool	 size	 and	 NAD+/NADH	
ratio (Figure 2) and was also upregulated in colon cancer tissues 
of	 patients	 (Figure	6).	 Consistently,	 NAMPT	 expression	 was	 cor-
related with colon cancer patient outcome regardless of the tumor 
staging	and	 induced	cancer	stem-	like	properties	 in	colon	cancer.24 
Furthermore,	 reduction	 of	 the	 NAD(H)	 pool	 by	 FK866	 treatment	
effectively	 inhibited	 AOM/DSS-	induced	 colon	 cancer	 (Figure	5),	
supporting	 that	NAMPT-	mediated	NAD(H)	pool	 increase	 could	be	
critical to colon cancer progression. In contrast, suppression of de 
novo	 NAD+	 synthesis	 by	 unconventional	 pre-	fold	 in	 RPB5	 inter-
actor	 (URI)	 expression	 is	 known	 to	 promote	 liver	 tumorigenesis	
in	 a	 diethylnitrosamine-	induced	 hepatocellular	 carcinoma	 mouse	
model.25	Therefore,	 it	would	be	worthwhile	 to	 further	 investigate	
whether	inhibition	of	salvage	NAD+	synthesis	by	NAMPT	knockout	
could affect cancer progression in a mouse model.
Because	 NADH	 is	 autofluorescent,	 whereas	 NAD+ is not, we 
examined	whether	NADH	levels	could	represent	 the	NAD(H)	pool	
size.	We	confirmed	that	NADH	levels	could	be	positively	correlated	
with	the	NAD(H)	pool	size	and	NAD(H)	levels	determined	by	enzy-
matic assays were also consistent with the fluorescence intensity 
determined	by	TPEF	microscopy	(Figures	1,	3	and	6).	These	results	
support	that	the	fluorescence	intensities	detected	by	TPEF	micros-
copy	could	represent	the	NAD(H)	pool	size.	Furthermore,	because	
NADPH	and	NADH	are	spectrally	identical,	we	investigated	the	ef-
fects	of	NADPH	levels	on	the	fluorescence	 intensity	using	a	TPEF	
microscope	at	a	740-	nm	wavelength.	Fluorescence	lifetime	imaging	
could	differentiate	between	NADPH	and	NADH	because	the	fluo-
rescence	lifetime	of	cellular	NADPH	could	be	distinct	from	that	of	
cellular	NADH	as	a	 result	of	 the	different	cofactors	bound	by	 the	
enzymes.26	 However,	 we	measured	 the	 total	 NADH	 and	 NADPH	
levels,	including	unbound	and	bound	forms.	Decreasing	the	NADPH	
level	through	G6PD	knockdown	did	not	significantly	affect	the	TPEF	
imaging	results	because	the	NADH	levels	were	approximately	2-	fold	
higher	 than	 those	of	NADPH	 (Figure	S1).	 In	 addition,	 the	NADPH	
level	should	also	sustain	cancer	cell	resistance	to	detrimental	oxida-
tive	stress	because	NADPH	is	an	antioxidant	molecule.	Thus,	imaging	
by	TPEF	microscopy	at	a	740-	nm	wavelength	could	indicate	the	re-
sistance	to	therapies	that	can	induce	oxidative	stress.	Furthermore,	
Wang	 et	al27 showed the typical glandular structures of normal 
mouse	colon	by	TPEF	endoscopy	as	well.	Therefore,	NADH	imaging	
by	TPEF	endoscopy	could	be	a	potential	strategy	for	CRC	diagnosis.
Reactive	oxygen	species	can	act	as	anti-	tumorigenic	agents,	de-
pending on the cell and tissue types, the location of ROS produc-
tion,	the	individual	ROS	levels	and	the	antioxidant	capacity	of	cancer	
cells.28	Cancer	cells	 that	 survive	despite	oxidative	 stress	are	 likely	
to	have	acquired	adaptive	mechanisms	to	counteract	the	potential	
toxic	 effects	 of	 elevated	 ROS.10 In a previous study, we reported 
that	NAMPT	could	increase	the	antioxidant	capacity	of	cancer	cells	
and	induce	cancer	cell	survival	under	excessive	oxidative	stress	upon	
glucose deprivation.15	Consistently,	NAMPT	expression	was	not	in-
duced	by	H2O2 treatment in normal cells, but it was dramatically in-
creased	in	CRC	cells	(Figure	4C),	indicating	that	NAMPT	expression	
in	 tumor	 tissues	 could	 be	 increased	 due	 to	 inflammation-	induced	
ROS	production.	In	tissues	of	CRC	patients,	both	mRNA	and	protein	
levels	of	NAMPT	were	also	upregulated	(Figure	6F-	I).	 Interestingly,	
tumor	tissues	with	high	levels	of	NADH	fluorescence	exhibited	de-
creased ROS levels relative to surrounding tissues with low levels 
of	 NADH	 (Figure	4A).	 Moreover,	 FK866	 treatment	 decreased	 the	
NAD(H)	pool	size,	increased	detrimental	ROS	levels	and	reduced	the	
colon	tumor	size	in	AOM/DSS	mice	(Figure	5).	Therefore,	our	results	
support	that	NAMPT-	mediated	NAD(H)	pool	increase	could	promote	
colon	cancer	progression	by	decreasing	detrimental	oxidative	stress.
Interestingly,	 NAMPT	was	 upregulated	 in	 both	 cancer	 and	 in-
flammatory	 immune	 cells	 (Figure	 S2).	 A	 previous	 report	 revealed	
that	 immune	 cells	 recruited	 into	DSS-	induced	 colitis	 tissues,	 such	
as	macrophages,	 dendritic	 cells,	 T	 cells	 and	natural	 killer	 cells,	 ex-
hibited	upregulated	NAMPT	expression,	and	FK866	treatment	de-
creased inflammatory responses.16	 Consistently,	 the	 IFN-	γ levels 
were	reduced	in	FK866-	treated	AOM/DSS	tissues	(Figure	S4).	Taken	
together,	 the	 increases	 in	 the	 NAD(H)	 pool	 mediated	 by	 NAMPT	
could	suppress	excessive	oxidative	stress-	induced	cell	death	in	can-
cer cells and promote inflammatory cytokine production in immune 
cells,	leading	to	inflammation-	induced	CRC	progression.	Therefore,	
FK866 treatment increased detrimental ROS levels in cancer cells 
and decreased inflammatory cytokine levels in immune cells, inhibit-
ing colon cancer progression.
In conclusion, we investigated the correlation between the 
NAD(H)	 pool	 size	 and	 CRC	 progression	with	 its	 clinical	 implica-
tions.	We	confirmed	that	the	NAD(H)	pool	size	and	NAD+/NADH	
ratio	could	increase	during	CRC	progression	due	to	the	increasing	
influx	of	NAD+,	which	was	mediated	by	NAMPT.	NAMPT-	mediated	
increases	 in	the	NAD(H)	pool	size	should	promote	 inflammation-	
induced	 CRC	 progression	 by	 decreasing	 the	 detrimental	 effects	
associated	with	excessive	ROS	accumulation.	Furthermore,	NADH	
might	 serve	 as	 a	 useful	 non-	invasive	marker	with	 intrinsic	 auto-
fluorescence properties because its levels could represent the 
NAD(H)	pool	size.	Based	on	our	findings,	the	non-	invasive	detec-
tion	 of	 NADH	 by	 TPEF	microscopy	 could	 offer	 a	 novel	 imaging	
method	for	CRC	progression.
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